作者
Aleksander Dokollari, Matteo Cameli, Giulia Elena Mandoli, Didar-Karan S Kalra, Robert Poston, Lindita Coku, Marjela Pernoci, Mirian Miri, Massimo Bonacchi, Sandro Gelsomino
发表日期
2021/11/1
期刊
Journal of Cardiothoracic and Vascular Anesthesia
卷号
35
期号
11
页码范围
3223-3231
出版商
WB Saunders
简介
Objective
To compare early and midterm outcomes of transcatheter valve-in-valve implantation (ViV-TAVI) and redo surgical aortic valve replacement (re-SAVR) for aortic bioprosthetic valve degeneration.
Design
Patients who underwent ViV-TAVI and re-SAVR for aortic bioprosthetic valve degeneration between January 2010 and October 2018 were retrospectively analyzed. Mean follow-up was 3.0 years.
Setting
In-hospital, early, and mid-term outcomes.
Participants
Eighty-eight patients were included in the analysis.
Interventions
Thirty-one patients (37.3%) had ViV-TAVI, and 57 patients (62.7%) had re-SAVR.
Measurements and Main Results
In the ViV-TAVI group, patients were older (79.1 ± 7.4 v 67.2 ± 14.1, p < 0.01). The total operative time, intubation time, intensive care unit length of stay, total hospital length of stay, inotropes infusion, intubation >24 hours, total amount of chest tube losses, red blood cell …
引用总数